D. Moore

发表

Discovery of novel and potent leukotriene B4 receptor antagonists. Part 1.

Y. Li, N. Fotouhi, Romyr Dominique, 2010, Journal of medicinal chemistry.

Identification of RO4597014, a Glucokinase Activator Studied in the Clinic for the Treatment of Type 2 Diabetes.

S. Berthel, Y. Qian, D. Choi, 2013, ACS medicinal chemistry letters.

Discovery of piragliatin--first glucokinase activator studied in type 2 diabetic patients.

J. Grippo, F. Matschinsky, P. Mahaney, 2012, Journal of medicinal chemistry.

Effects of LTB4 receptor antagonism on pulmonary inflammation in rodents and non-human primates.

Y. Li, N. Fotouhi, K. Dabbagh, 2010, Prostaglandins & other lipid mediators.

2,3-Disubstituted acrylamides as potent glucokinase activators.

J. Grippo, A. Sidduri, J. Lou, 2010, Bioorganic & medicinal chemistry letters.

Automated high throughput human CYP isoform activity assay using SPE-LC/MS method: application in CYP inhibition evaluation

N. Olejnik, D. Moore, H. Satoh, 2000, Xenobiotica; the fate of foreign compounds in biological systems.

In Vitro and in Vivo Induction of Cytochrome P450: A Survey of the Current Practices and Recommendations: A Pharmaceutical Research and Manufacturers of America Perspective

Vikram Sinha, Heidi J Einolf, Michael Sinz, 2009, Drug Metabolism and Disposition.

Inhibition and kinetics of cytochrome P4503A activity in microsomes from rat, human, and cdna-expressed human cytochrome P450.

P. Thomas, A. Ghosal, D. Moore, 1996, Drug metabolism and disposition: the biological fate of chemicals.

Evaluation of a New Molecular Entity as a Victim of Metabolic Drug-Drug Interactions—an Industry Perspective

David Moore, Yuan Chen, Louis Leung, 2016, Drug Metabolism and Disposition.

In Vitro and In Vivo Induction of Cytochrome P 450 : A Survey of the Current Practices and Recommendations : A Pharmaceutical Research and Manufacturers of America ( PhRMA ) Perspective

R. Evers, V. Sinha, D. Moore, 2009 .

A single-dose mass balance and metabolite-profiling study of vemurafenib in patients with metastatic melanoma

R. Dummer, A. Joe, J. Grippo, 2015, Pharmacology research & perspectives.

Substrate dependent inhibition profiles of fourteen drugs on CYP3A4 activity measured by a high throughput LCMS/MS method with four probe drugs, midazolam, testosterone, nifedipine and terfenadine.

H. Satoh, N. Olejnik, D. Moore, 2003, Drug metabolism and pharmacokinetics.